2. Clinical PK consideration in
elderly
By
Dr. Ahmed Shaker
Ali
Dept of pharmacology
Faculty of medicine
Ahmedshaker21@ yahoo.
com
Bl 7. G751 Ex. 22330
5th yr dental 11 -2-1434
3. An elderly with renal impairment , what the appropriate
regimen of Augmentin ?
Leaflet of the drug mentioned
Patients with impaired renal function do not generally require a reduction in
dose unless the impairment is severe. Severely impaired patients with a
glomerular filtration rate of <30 mL/min. should not receive the 875-mg
tablet. Patients with a glomerular filtration rate of 10 to 30 mL/min. should
receive 500 mg or 250 mg every 12 hours, depending on the severity of the
infection. Patients with a less than 10 mL/min. glomerular filtration rate
should receive 500 mg or 250 mg every 24 hours, depending on severity of
the infection.
Hemodialysis patients should receive 500 mg or 250 mg every 24 hours,
depending on severity of the infection. They should receive an additional
dose both during and at the end of dialysis.
4. How about Voltaren ?
Special Populations
Hepatic Insufficiency: Hepatic metabolism accounts for almost 100%
of Voltaren elimination, so patients with hepatic disease may require
reduced doses of Voltaren compared to patients with normal hepatic
function.
Renal Insufficiency: Diclofenac pharmacokinetics has been
investigated in subjects with renal insufficiency. No differences in the
pharmacokinetics of diclofenac have been detected in studies of
patients with renal impairment. In patients with renal impairment
(inulin clearance 60-90, 30-60, and < 30 mL/min; N=6 in each group),
AUC values and elimination rate were comparable to those in healthy
subjects.
BUT elderly are more predisposed for ADE specially renal impairment
5. OBJECTIVES
– To optimize use of drugs in elderly
TOPICS
– Introduction
– Reduced renal function with aging
– Assessment of renal function
– Dose adjustment in renal impairment
– Liver disease
– Other PK variables
6. Elderly may suffer one or more chronic disease
Multiple Diseases – ASHD
– CHF – Diabetes Mellitus
– COPD – Osteoporosis
– CRF
– DJD
– Chronic liver disease
– Dementia – Others
7. Aging is associated with normal
changes
Relative increased in fat ?
Decreased bone density
Decreased muscle
Decreased water content
– Ref: Cefalu CA. Clinical Pharamcology. In: Burke MM &
Laramie JA. Primary Care of the Older Adult. 2000, p. 90.
8. Normal Physiological Changes of the
Organ Systems
Liver- decreased blood flow;
Decreased Phase I Metabolism
Kidney- decreased creatinine clearance with
advanced age
CNS-increased risk of confusional states primarily
secondary to anti-cholinergic agents
Intestinal tract-- malabsorption-- not clinically significant
in absence of disease
9. Normal Changes of Aging-Hepatic
Phase I Metabolism-rate of metabolism
slows (oxidation, reduction, hydroxylation)
Phase II Metabolism-rate stays the same
(conjugation with glucronic acid, sulfation
methylation, acetylation)
– Examples-benzodiazepines
» Short acting-Phase II only-appropriate
» Long acting-Phase I and II-inappropriate, long half-lives
Reference: Beers MH. Medication Use in the Elderly. In: Calkins ,
Ford & Katz, 1992, p. 40.
10. Normal Changes of Aging :-Renal
Age-related reduction in renal blood
flow and creatinine clearance in the
face of a normal BUN and serum
creatinine:
Implications-
– Adjust dose of renally excreted drugs
with age according to creatinine
clearances (Clcr ) for certain drugs
11. Degree of renal impairments
for prescribing purposes
GFR : Ml/min renal impairment
20-50 mild
10-20 moderate
< 10 severe
12. Nephrotoxic drugs
1) Pre-renal
NSAIDs even short courses– renal
under- perfusion
ACE inhibitors ( angiotensin converting
enzyme ) in patient with compromised renal
perfusion
13. Nephrotoxic drugs cont
2) Intrarenal damage :
Glomerunephritis : Captopril, antibiotics
including pencillins , sulphonamides and
Rifampicin
Interstitial nephritis : Penicillin,
cephalosporines, NSAIDs and Rifampicin
Direct toxicity to renal tubules : aminoglycosides,
amphotercin, Cyclosporine A
14. Nephrotoxicity Cont
3-Biochemical changes :
Excessive vit D replacement : hypercalcemia –
precipitates or exacerbate renal impairment
Other : Cefixime rare cases
NSADs ; Analgesic
Analgesics :
nephropathy
Analgesic nephropathy have been most
commonly seen with combination analgesics that
contain aspirin and or Paracetamol
15. GFR & CKD
GFR is a direct measurement of kidney
function and reduced before the onset of
symptoms of kidney failure.
A decrease in GFR correlates with the
pathogenic severity of kidney disease.
Replacement therapy with dialysis or
transplantation becomes necessary when
the GFR decrease below 15mL/min/1.73m2.
16. (GFR tests).
Serum Creatinine : (Scr)
Simple.
Χ Misleading .
Χ Scr may remain constant although GFR decline
specially in elderly.
Χ Several variables : age, diet ,muscle mass etc
18. Disadvantages of 24 hr urine
collection
ΧTime consuming
ΧErrors in collection time / volume
ΧTroublesome to both patients & Lab
ΧMay over estimate GFR by 10-30 %
ΧEffect of drugs ??
19. Estimating creatinine clearance
Cockcroft & Gault equation
(modified )
Men: CrCl = 1.23 x (140 – Age) x Wt
SrCr
Women: CrCl = 1.04 x (140 – Age) x Wt x
SrCr
CrCl = Creatinine clearance (ml/min)
Age (Years)
Wt = Weight (kg)
SrCr = Serum creatinine (micromole/L l)
Ref: Ref: Cefalu CA. Clinical Pharmacology. In: Burke MM & Laramie JA.
Primary Care of the Older Adult. 2000, p. 92.
21. Clinical significance of renal
impairment
Prolonged half life (T1/2) is common
T1/2 = 0.693 x Vd
Cl
Longer dosing interval should be considered for
drugs which depends mainly on renal
elimination
Longer time is required to
1. Attain steady state
2. Or until body is drug-free in case of toxcicity
22. Methods of dose adjustment in renal impairment
If mild , drug has wide therapeutic range
usually no need to adjust the dose
• If moderate or severe , or the drug has
narrow therapeutic range , appropriate
adjustment is essential
• A- reduce the dose keep dosing interval as
normal
• B- normal dose but Longer dosing interval
23. Factors affecting drug metabolism
Main site of drug metabolism = LIVER
Drug metabolism can be affected by:
1. First pass effect
2. Hepatic blood flow
3. Liver disease
4. Drugs which alter liver enzymes
24. Factors affecting drug metabolism
I. Genetic factors
e.g acetylation status
I. Other drugs
o hepatic enzyme inducers
o hepatic enzyme inhibitors
I. Age
Impaired hepatic enzyme activity
o Elderly
o Children < 6 months (especially premature babies)
26. Enzyme Inhibiting Drugs
Inhibit the enzymes which break down
drugs
Decreased rate of drug breakdown
Smaller dose of affected drug needed to
produce the same clinical effect
29. Pharmaceutical Agents That Require
Hepatic Metabolism
Benzodiazepines
Cimetidine
Ranitidine
Famotidine
Terfenadine
Proton pump inhibitors
Schwartz JB. Clinical Pharmacology. In:
Hazzard WR et al. Principles of Geriatric
Medicine and Gerontology, 4th Ed., 2000, p. 309-
319.
30. The Cytochrome System
CYP1A2
CYP2C
CYP2D6
CYP3A
– Involves Model Compounds, Drug Substrates,
Inducers, and Inhibitors
– Ref: Schwartz JB. Clinical Pharmacology. In:
Hazzard WR et al. Principles of Geriatric Medicine
and Gerontology, 4th Ed., 2000, p. 308.
31. Particular Agents of Concern in the
Elderly-highly bound to protein
Phenytoin
Carbamazepine
Barbiturates
Warfarin
Malnutrition or hypoproteinemia is associated with
increased free fraction of drug and increased toxicity
Ref: Physicians Desk Reference, Medical Economics-
Thomson Healthcare,55th Edition, 2001, p. 2427.
32. Physiological changes of the GI Tract
Stomach- little change in gastric acidity with aging. In
presence of dsyphagia and H2 blocker therapy, may
increase risk of morbidity and mortality from pneumonia
(bacteria more viable after aspiration due to reduced
acidity)
Decreased GI motility and blood flow-- increased
frequency of constipation
– Ref: In: Hall KE, Wiley JW. Age-Associated Change in
Gastrointestinal Function. In: Hazzard WR et al. Principles of
Geriatric Medicine and Gerontology, 4th Ed., 2000, p. 835-842.
–
33. NSAIDs*:
Can Worsen HBP- removal of NSAID can affect mean
blood pressure control
Fluid retention
Worsen CHF
Cause confusion
GI bleeding
Newer Cox-2 agents, gastric sparring
Less risk of Alzheimer's and cognitive decline
*In high doses or used chronically
Ref: Carson JL & Strom BL. Use of Nonsteroidal Anti-Inflammatory Drugs.
In: Hazzard WR et al. Principles of Geriatric Medicine and Gerontology, 4 th
Ed., 2000, p. 1113-1119; Stewart WF et al. Risk of Alzheimer’s disease and
duration of NSAID use. Neurology, 48, 1997, p. 626-632.
34. “Tips” for Safe Traditional
NSAID Use
Substitute acetaminophen when possible instead
of NSAID
Guide the patient to avoid misuse of
acetaminophen.
Use PRN when possible
Use lowest dose possible
Use for acute flare for 7-10 days then d/c
When necessary for chronic use, insist on routine
q 3 month. RFT &LFT & and CBC
Consider institutional changes to allow relatively
safe analgesics
35. . المقامة اليمانية لصفات الصادقين
ال صا دق في إيمانه
ّ ِ
يؤمن بالله وملئكته وكتبه ورسله واليوم الخر والقدر خيره
وشره
يحب الرسول ويطيعه فيما أمر ويحب أصحاب رسول ا جميعا
وكذلك أمهات المؤمنين وأهل بيته أجمعين . يعتقد أنهم خير
القرون ويعرض عما يروجه أهل الضلل من شبهات وظنون .
عقيدته التباع وترك البتداع . يؤمن بان ا أتم نوره وأكمل
دينه ورضي السلم دينا
وان القوانين الوضعية منبوذة وضيعه وانه ل يصح إيمان من
عادى أو عطل الشريعة .
يوقن إن الشرك أعظم الظلم وان ا ل يغفر أن يشرك به
ويغفر ما دونه من الذنوب .
ل يدعو مع ا أحدا ول يستعن بسواه ول يسال غيره قضاء
الحوائج وتفريج الكروب .
يحب في ا المؤمنين ويبغض في ا الكفار والمنافقين .
يكثر من النوافل ويحافظ على الفرائض - يشهد الجماعات -
ويسارع في الخيرات .
يعظم القرءان ف يتعلم ه ويعلمه – ويتدبره ويعمل بمحكمه
36. .المقامة اليمانية لصفات الصادقين
نظره اعتبار وصمته فكر وكلمه خير وذكر -ل ينشغل بما ل
يعنيه ول يطلب فوق ما يكفيه .
أ ذا ابتلى صبر و إذا أعطي شكر و إذا س ئ ل بذل و إذا عز تواضع
َِ ُِ َ َِ َِ َ
و إذا تولى أمرا رفق .
َِ
موقر للكبير رحيم بالصغير – يوف بالعهد أمين – ويسعى على
اليتيم والمسكين
تراه دوما حليما وإذا مر باللغو مر كريما .
يحرص على هدى وسنة محمد صلى ا عليه وسلم خير النام –
ويصل الرحام ويفشى السلم – ويطعم الطعام ويصلى والناس
نيام .
– يأمر بالمعروف وينهى عن المنكر ويجاهد بماله ونفسه في
سبيل ا متبعا للشريعة - ول يسب أهل الكفر والضلل
والجاهلين سدا للزر يعه .
علم أن صلح القلب هو أصل صلح الجسد - فلم يحمل في
قلبه حقدا ول حسد –
و علم إن العمال بالنيات - فتحرى الخلص وداوم على
سؤال ا العون على الثبات .
لم تغره زخارف دار ا لغ رور عن أحوال القبور و أهوال ي وم
َ ْ َ ْ ُ َ
Notas del editor
* Chronic interstitial nephritis and papillary necrosis
The
FIRST PASS METABOLISM May render a drug ineffective by mouth e.g. lignocaine, insulin May mean that much higher dose needed orally to produce the same effect e.g. 5mg propranolol IV = 100mg propranolol PO Can use sub-lingual or rectal route e.g GTN get absorption directly into systemic circulation and bypass the liver initially LIVER DISEASE The liver has a large capacity and metabolism is only affected in extensive liver disease. Intravenous shunting in the absence of much hepatocellular damage can impair drug metabolism e.g. in liver cirrhosis HEPATIC BLOOD FLOW Liver receives blood from the portal vein and the hepatic artery. The hepatic clearance of a drug depends on hepatic blood flow and the hepatic extraction ratio. Free drug (dissociated from plasma proteins or partitioned out of blood cells) passes across hepatocyte membrane and undergoes either biliary excretion or metabolism by an enzyme. Drugs with a high extraction ratio (approaching 1) - none of these processes is slow or rate limiting. Hepatic clearance depends on the rate of hepatic blood flow. Drugs with a low extraction ratio - one of the processes is slow and rate limiting e.g. poor diffusion into hepatic cell, slow diffusion out of blood cell, tight binding to plasma proteins. Drug concentration is almost the same in venous and arterial blood and hepatic clearance is independent of blood flow .